158 related articles for article (PubMed ID: 21228369)
21. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood.
Wiersma SR; Ortega J; Sobel E; Weinberg KI
N Engl J Med; 1991 Mar; 324(12):800-8. PubMed ID: 1997852
[TBL] [Abstract][Full Text] [Related]
22. Peroxidase-negative and myelomonocytic antigen-positive acute leukemia.
Okawa H; Nagasawa M; Morio T; Takase K; Tanaka K; Yata J; Dan K; Nomura T; Sakamaki H; Onozawa Y
Int J Hematol; 1992 Apr; 55(2):165-71. PubMed ID: 1324747
[TBL] [Abstract][Full Text] [Related]
23. The specificity of immunophenotypic alterations in blasts in nonacute myeloid disorders.
Harrington A; Olteanu H; Kroft S
Am J Clin Pathol; 2010 Nov; 134(5):749-61. PubMed ID: 20959658
[TBL] [Abstract][Full Text] [Related]
24. Acute myeloid leukemia possibly producing thrombopoietic factor(s).
Fujita A; Matsuoka M; Shimonaka Y; Imai N; Asano S
Jpn J Clin Oncol; 1993 Dec; 23(6):366-72. PubMed ID: 7506802
[TBL] [Abstract][Full Text] [Related]
25. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D
Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765
[TBL] [Abstract][Full Text] [Related]
26. Characterization of CD34+, CD13+, CD33- cells, a rare subset of immature human hematopoietic cells.
Gaipa G; Coustan-Smith E; Todisco E; Maglia O; Biondi A; Campana D
Haematologica; 2002 Apr; 87(4):347-56. PubMed ID: 11940478
[TBL] [Abstract][Full Text] [Related]
27. Acute myeloid dendritic cell leukaemia with specific cutaneous involvement: a diagnostic challenge.
Ferran M; Gallardo F; Ferrer AM; Salar A; Pérez-Vila E; Juanpere N; Salgado R; Espinet B; Orfao A; Florensa L; Pujol RM
Br J Dermatol; 2008 May; 158(5):1129-33. PubMed ID: 18294313
[TBL] [Abstract][Full Text] [Related]
28. Correspondence re: Kaiserling E, Horny HP, Geerts M-L, Schmid U: Skin involvement in myelogenous leukemia: morphologic and immunophenotypic heterogeneity of skin infiltrates. Mod Pathol 7:771, 1994.
Orazi A
Mod Pathol; 1995 Apr; 8(3):340-1. PubMed ID: 7542388
[No Abstract] [Full Text] [Related]
29. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
30. Mast cell tryptase and microphthalmia transcription factor effectively discriminate cutaneous mast cell disease from myeloid leukemia cutis.
Sundram UN; Natkunam Y
J Cutan Pathol; 2007 Apr; 34(4):289-95. PubMed ID: 17381798
[TBL] [Abstract][Full Text] [Related]
31. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
Imamura N; Kuramoto A; Kawaguchi Y; Tanaka R
Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276
[TBL] [Abstract][Full Text] [Related]
32. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
[TBL] [Abstract][Full Text] [Related]
33. Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group.
Tsagarakis NJ; Kentrou NA; Papadimitriou KA; Pagoni M; Kokkini G; Papadaki H; Pappa V; Marinakis T; Anagnostopoulos NI; Vadikolia C; Anagnostopoulos A; Angelopoulou MK; Terpos E; Poziopoulos C; Anargyrou K; Rontogianni D; Papadaki T; Psarra A; Kontopidou FN; Skoumi D; Papadhimitriou SI; Paterakis G;
Leuk Res; 2010 Apr; 34(4):438-46. PubMed ID: 19793612
[TBL] [Abstract][Full Text] [Related]
34. Use of classic and novel immunohistochemical markers in the diagnosis of cutaneous myeloid sarcoma.
Amador-Ortiz C; Hurley MY; Ghahramani GK; Frisch S; Klco JM; Lind AC; Nguyen TT; Hassan A; Kreisel FH; Frater JL
J Cutan Pathol; 2011 Dec; 38(12):945-53. PubMed ID: 22050091
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-M0). Evaluation and a proposal.
Kaleem Z; White G
Am J Clin Pathol; 2001 Jun; 115(6):876-84. PubMed ID: 11392885
[TBL] [Abstract][Full Text] [Related]
36. Intracellular markers in acute myeloid leukemia diagnosis.
Koníková E; Glasová M; Kusenda J; Babusíková O
Neoplasma; 1998; 45(5):282-91. PubMed ID: 9921916
[TBL] [Abstract][Full Text] [Related]
37. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
38. Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm.
Sangle NA; Schmidt RL; Patel JL; Medeiros LJ; Agarwal AM; Perkins SL; Salama ME
Mod Pathol; 2014 Aug; 27(8):1137-43. PubMed ID: 24390220
[TBL] [Abstract][Full Text] [Related]
39. Plasmacytoid T-zone cell proliferation in a patient with chronic myelomonocytic leukemia. Histologic and immunohistologic characterization.
Harris NL; Demirjian Z
Am J Surg Pathol; 1991 Jan; 15(1):87-95. PubMed ID: 1845925
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: a rare condition distinct from blastic plasmacytoid dendritic cell neoplasm.
Dargent JL; Delannoy A; Pieron P; Husson B; Debecker C; Petrella T
J Cutan Pathol; 2011 Nov; 38(11):893-8. PubMed ID: 21883371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]